News

Aurobindo Pharma arm gets U.S. FDA nod for generic of BMS’ cancer drug
Aurobindo Pharma's Eugia Pharma approved to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel, ...
Stock market update: Nifty Pharma index advances 1.4%
Benchmark NSE Nifty50 index ended up 161.71 points at 24328.95, while the BSE Sensex stood up 520.9 points at 80116.49. Among ...
Trade Brains2d
Pharma stock jumps 5% after receiving USFDA approval to manufacture cancer-treating drug
The shares of the Mid-Cap company specializing in the development, manufacturing, and commercialization of generic ...
CNBCTV182d
Stock Market Highlights: Market gains for seventh consecutive session, Nifty hits four-month high
The Nifty reclaimed the 24,300 mark, ending the day at 24,329 after a gain of 162 points, while the Sensex surged 521 points ...
Aurobindo Pharma in focus: Why has the stock gained 3% in trade today?
The up move in the stock came after the company arm Eugia Pharma Specialities, received final approval from USFDA to ...
CNBCTV182d
Aurobindo Pharma shares gain nearly 3% after getting USFDA nod for leukemia drug
Aurobindo Pharma's shares rose nearly 3% after its subsidiary, Eugia Pharma, received USFDA approval to market Dasatinib ...
Aurobindo Pharma arm Eugia gets USFDA nod for Dasatinib tablets, eyes $1.8 billion market
Eugia Pharma, a subsidiary of Aurobindo Pharma, has secured final USFDA approval for manufacturing and marketing Dasatinib ...
Aurobindo Pharma rallies after arm receives USFDA nod for Dasatinib tablets
Aurobindo Pharma rose 1.81% to Rs 1,209.60 after its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and ...
LiveLaw2d
Patent Pooling And Diffusion Of Green Technology: A Critical Analysis
Patent pool is a consortium of two or more patent-holders to promote a particular technology and share the market ...